Lynch, R. C., Poh, C., Shadman, M., Till, B. G., Di, M., Ujjani, C. S., Raghunathan, V., Smith, S. D., Maloney, D., Gausman, D., Rasmussen, H., Russler-Germain, D. A., Fehniger, T. A., Kurtz, D. M., Alizadeh, A., Voutsinas, J., Gopal, A. K. (2026). Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02906